INDAPAMIDE ZENTIVA LP 1.5 mg, extended-release film-coated tablet 30 tablets
Active ingredients: Indapamide, Indapamide hemihydrate
Commercialized according to BDPMDispensing in France: Prescription only
Extended-release film-coated tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- INDAPAMIDE ZENTIVA LP 1,5 mg, comprimé pelliculé à libération prolongée
- Pharmaceutical form
- comprimé pelliculé à libération prolongée
- Route of administration
- orale
- Presentation description
- plaquette(s) aluminium PVC PVDC de 30 comprimé(s)
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 17 Apr 2009
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69733040CIP73883916CIP133400938839166Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| INDAPAMIDEcomprimé | 1,5 mg · un comprimé | FT |
| INDAPAMIDE HÉMIHYDRATÉcomprimé | 1,54 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.